Borosil Scientific Ltd Stock Falls to 52-Week Low of Rs.99.3

Recent Price Movement and Market Context

On the day the stock hit this new low, it recorded a day change of -0.63%, despite outperforming its sector by 4.76%. The stock has been on a losing streak for two consecutive sessions, delivering a cumulative return of -2.57% during this period. Borosil Scientific is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum.

In comparison, the Glass sector, to which Borosil belongs, has experienced a sharper decline of -5.46%, indicating that while the stock is under pressure, it has marginally outperformed its sector peers in the short term. The broader market, represented by the Sensex, opened sharply lower by 2,743.46 points but recovered 1,150.39 points to trade at 79,694.12, still down 1.96% for the day. The Sensex itself remains below its 50-day moving average, though the 50DMA is positioned above the 200DMA, suggesting mixed technical signals at the index level.

Long-Term Performance and Valuation Metrics

Over the past year, Borosil Scientific’s stock has declined by 20.32%, contrasting with the Sensex’s positive return of 8.88% over the same period. The stock’s 52-week high was Rs.190.45, underscoring the extent of the recent decline. This underperformance is further reflected in the company’s valuation and profitability metrics.

The company’s return on equity (ROE) stands at a modest 4.53%, indicating limited profitability relative to shareholders’ funds. This figure has contributed to the stock’s current “Sell” Mojo Grade of 37.0, which was downgraded from a “Strong Sell” on 11 Feb 2026. The market capitalisation grade is rated 4, reflecting the company’s mid-tier size within its sector.

Borosil Scientific’s price-to-book value ratio is 2.3, which is considered expensive given the company’s low ROE and growth rates. Despite this, the stock is trading at a discount relative to its peers’ historical valuations, suggesting that the market has factored in the company’s recent performance challenges.

Growth and Profitability Trends

Over the last five years, Borosil Scientific’s net sales have grown at an annual rate of 9.80%, while operating profit has increased at a slower pace of 2.86%. This disparity highlights challenges in converting sales growth into operating profitability. However, the company reported an 11% rise in profits over the past year, despite the stock’s negative price performance.

Quarterly results released in December 2025 showed some improvement, with profit before tax excluding other income (PBT LESS OI) reaching Rs.12.15 crores, a growth of 154.5% compared to the previous four-quarter average. Operating profit before depreciation and interest (PBDIT) also hit a quarterly high of Rs.17.19 crores, with operating profit to net sales ratio peaking at 14.17%. These figures suggest pockets of operational improvement, although they have yet to translate into sustained positive momentum for the stock price.

Shareholding and Market Participation

Despite the company’s size, domestic mutual funds hold a minimal stake of just 0.04%. Given that mutual funds typically conduct detailed research and due diligence, this limited exposure may reflect a cautious stance towards the company’s current valuation and business outlook. The stock has also underperformed the BSE500 index over the last three years, one year, and three months, indicating consistent challenges in delivering market-beating returns.

Financial Stability and Debt Profile

Borosil Scientific maintains a conservative capital structure with an average debt-to-equity ratio of zero, indicating no reliance on debt financing. This low leverage reduces financial risk but also limits potential growth leverage through borrowing. The company’s cautious approach to debt aligns with its steady but modest growth trajectory.

Summary of Key Metrics

To summarise, Borosil Scientific’s current market position is characterised by a 52-week low price of Rs.99.3, a Mojo Score of 37.0 with a “Sell” grade, and a market cap grade of 4. The stock’s valuation metrics, including a price-to-book ratio of 2.3 and a low ROE of 4.53%, reflect subdued profitability and growth prospects. While recent quarterly results show some improvement in profitability ratios, the stock continues to trade below all major moving averages and has underperformed both its sector and broader market indices over multiple time frames.

These factors collectively illustrate the challenges faced by Borosil Scientific Ltd in maintaining investor confidence and market valuation amid a competitive industrial products sector.

Only Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Start Today